DAZAP1 Activators comprise a spectrum of chemical entities that indirectly augment DAZAP1's functional capacity within various cellular contexts, particularly concerning its role in RNA metabolism. Forskolin and Rolipram exert their effects by elevating cAMP levels, with Forskolin directly activating adenylate cyclase and Rolipram inhibiting phosphodiesterase 4, thus preventing cAMP degradation. The resultant elevated cAMP levels activate PKA, which may phosphorylate proteins that interface with DAZAP1, thereby enhancing DAZAP1's RNA-binding and regulatory functions. Ionomycin and A23187, both calcium ionophores, increase intracellular calcium, which could activate calcium-dependent kinases and phosphatases, potentially affecting DAZAP1's function in mRNA transport and stabilization. Phorbol 12-myristate 13-acetate (PMA) activates PKC, which may phosphorylate substrates that interact with DAZAP1, influencing its role in RNA splicing and export. Okadaic acid, a protein phosphatase inhibitor, sustains the phosphorylation of proteins that could include DAZAP1 interactants, potentially enhancing DAZAP1's involvement in mRNA processing.
Additional DAZAP1 activators like 8-Br-cAMP, a cAMP analog, and epigallocatechin gallate (EGCG), a kinase inhibitor, could fine-tune cellular signaling to favor DAZAP1-mediated pathways. 8-Br-cAMP activates PKA, leading to a potential increase in phosphorylation of DAZAP1-associated proteins, while EGCG might suppress competitive kinase signaling, indirectly facilitating DAZAP1's mRNA regulatory functions. Sphingosine-1-phosphate initiates a cascade via G-protein-coupled receptors that can intersect with pathways involving RNA-binding proteins like DAZAP1. PI3K inhibitors LY294002 and Wortmannin may shift intracellular signaling, indirectly potentiating DAZAP1's role in post-transcriptional gene regulation. Lastly, Thapsigargin, by inhibiting the SERCA pump, leads to elevated cytosolic calcium that might influence DAZAP1's function in mRNA editing and stability through calcium-dependent signaling pathways. Collectively, these compounds, through their targeted molecular effects, facilitate the enhancement of DAZAP1's biological activities.
SEE ALSO...
Items 1 to 10 of 20 total
Display:
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
5-Azacytidine | 320-67-2 | sc-221003 | 500 mg | $280.00 | 4 | |
Could inhibit DNA methyltransferases, potentially leading to hypomethylation and reduced expression of TMEM145. | ||||||
Forskolin | 66575-29-9 | sc-3562 sc-3562A sc-3562B sc-3562C sc-3562D | 5 mg 50 mg 1 g 2 g 5 g | $78.00 $153.00 $740.00 $1413.00 $2091.00 | 73 | |
Forskolin activates adenylate cyclase, increasing intracellular cAMP levels, which in turn activates PKA. PKA phosphorylates various target proteins, potentially including those that may interact with DAZAP1, enhancing its RNA-binding and modulation of mRNA metabolism. | ||||||
Trichostatin A | 58880-19-6 | sc-3511 sc-3511A sc-3511B sc-3511C sc-3511D | 1 mg 5 mg 10 mg 25 mg 50 mg | $152.00 $479.00 $632.00 $1223.00 $2132.00 | 33 | |
Histone deacetylase inhibitor that may increase histone acetylation, potentially changing TMEM145 expression. | ||||||
Rolipram | 61413-54-5 | sc-3563 sc-3563A | 5 mg 50 mg | $77.00 $216.00 | 18 | |
Rolipram is a selective inhibitor of phosphodiesterase 4, preventing cAMP degradation, which could lead to increased PKA activity. PKA may phosphorylate proteins that associate with DAZAP1, thereby indirectly enhancing DAZAP1's RNA-binding activity. | ||||||
Ionomycin | 56092-82-1 | sc-3592 sc-3592A | 1 mg 5 mg | $78.00 $270.00 | 80 | |
Ionomycin is a calcium ionophore that increases intracellular calcium levels, potentially modulating calcium-dependent phosphorylation events that could affect DAZAP1's function in mRNA transport and stabilization. | ||||||
Mithramycin A | 18378-89-7 | sc-200909 | 1 mg | $55.00 | 6 | |
Binds to DNA and may interfere with transcription factor binding, potentially reducing TMEM145 transcription. | ||||||
PMA | 16561-29-8 | sc-3576 sc-3576A sc-3576B sc-3576C sc-3576D | 1 mg 5 mg 10 mg 25 mg 100 mg | $41.00 $132.00 $214.00 $500.00 $948.00 | 119 | |
PMA activates protein kinase C (PKC), which could phosphorylate substrates that interact with DAZAP1, possibly affecting its role in RNA splicing and export. | ||||||
5-Aza-2′-Deoxycytidine | 2353-33-5 | sc-202424 sc-202424A sc-202424B | 25 mg 100 mg 250 mg | $218.00 $322.00 $426.00 | 7 | |
Another DNA methyltransferase inhibitor that could affect the methylation and expression of the TMEM145 gene. | ||||||
Okadaic Acid | 78111-17-8 | sc-3513 sc-3513A sc-3513B | 25 µg 100 µg 1 mg | $291.00 $530.00 $1800.00 | 78 | |
Okadaic acid is an inhibitor of protein phosphatases PP1 and PP2A, leading to increased phosphorylation of cellular proteins, which could include those associated with DAZAP1, potentially enhancing its role in mRNA processing. | ||||||
α-Amanitin | 23109-05-9 | sc-202440 sc-202440A | 1 mg 5 mg | $269.00 $1050.00 | 26 | |
Inhibits RNA polymerase II, potentially reducing mRNA synthesis of genes, including TMEM145. | ||||||